Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells | Zendy

JyhCheng Chen | Zendy; Chia-Hung Wu | Zendy; Yi-Shuan Peng | Zendy; HaoYu Zheng | Zendy; Yuan-Cheng Lin | Zendy; Peng-Fang Ma | Zendy; Ting-Chuan Yen | Zendy; TzuYing Chen | Zendy; YunWei Lin | Zendy

Open Access

Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells

Author(s) -

JyhCheng Chen,

Chia-Hung Wu,

Yi-Shuan Peng,

HaoYu Zheng,

Yuan-Cheng Lin,

Peng-Fang Ma,

Ting-Chuan Yen,

TzuYing Chen,

YunWei Lin

Publication year - 2018

Publication title -

toxicology research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.709

H-Index - 31

eISSN - 2045-4538

pISSN - 2045-452X

DOI - 10.1039/c7tx00292k

Subject(s) - xeroderma pigmentosum , astaxanthin , complementation , lung cancer , cytotoxicity , cancer research , erlotinib , chemistry , p38 mitogen activated protein kinases , medicine , cancer , mapk/erk pathway , pharmacology , biochemistry , oncology , signal transduction , dna damage , gene , dna , epidermal growth factor receptor , in vitro , carotenoid , phenotype

Astaxanthin has been demonstrated to exhibit a wide range of beneficial effects that include anti-cancer and anti-inflammatory properties.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research